中文名称: | AM251 | ||||
---|---|---|---|---|---|
英文名称: | AM251 | ||||
别名: | 1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-(哌啶-1-基)-1H-吡唑-3-甲酰胺 1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide | ||||
CAS No: | 183232-66-8 | 分子式: | C22H21Cl2In4O | 分子量: | 555.24 |
CAS No: | 183232-66-8 | ||||
分子式: | C22H21Cl2In4O | ||||
分子量: | 555.24 | ||||
MDL: | MFCD01861181 |
基本信息
产品编号: |
A11441 |
||||
产品名称: |
AM251 |
||||
CAS: |
183232-66-8 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
555.24 |
-20℃ |
1个月 |
||
化学名: |
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
40mg/mL (72.04mM) |
|||
Ethanol |
Insoluble |
||||
Water |
Insoluble |
||||
体内(现配现用): |
5% DMSO+40% PEG 300+5% Tween 80+50% ddH2O |
1mg/mL |
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
1.8010mL |
9.0051mL |
18.0102mL |
5mM |
0.3602mL |
1.8010mL |
3.6020mL |
10mM |
0.1801mL |
0.9005mL |
1.8010mL |
50mM |
0.0360mL |
0.1801mL |
0.3602mL |
生物活性
产品描述 |
一种选择性大麻素1 (CB1)受体拮抗剂,IC50为8nM。AM25也是GPR55 的激动剂,EC50为39nM。 |
靶点 |
IC50:8nM (CB1 receptor) |
体外研究 |
AM251 is a CB1 receptor antagonist/inverse agonist.AM251 produces an agonist response in HEK293 cells,similar to that found in the yeast expression system.AM-251 reduces cholesteryl ester synthesis in unstimulated and acetylated LDLstimulated Raw 264.7 macrophages,CB2+/+and CB2-/-peritoneal macrophages. |
体内研究 |
The CB1 antagonist AM251 (3mg/kg,i.p.) decreases capsaicin-evoked nocifensive behavior (F1,18=28.45,p<0.0001).This suppressive effect is genotype dependent (F1,18=14.83,p<0.01),and the interaction between the effects of genotype and AM251 approached significance (F1,18=4.704,p=0.0587).Planned comparisons reveal that AM251 reduces nocifensive behaviors in fatty-acid amide hydrolase (FAAH) KO mice (p<0.01) but fails to alter nocifensive behavior in WT mice (p>0.2) relative to their respective vehicle controls. AM251 (3mg/kg,i.p.) reduces the duration of heat hypersensitivity in FAAH KO (F 1,9=21.43,p<0.01) but not WT mice (p>0.3).AM251 suppresses capsaicin-evoked heat hypersensitivity in a time-dependent manner in FAAH KO (F5,9=4.349,p<0.01) but not in WT mice (p>0.3).Post-hoc analysis reveals that FAAH KO mice receiving vehicle (i.p.) display heightened thermal hypersensitivity at 30 (p<0.05),60 (p<0.05),and 90 (p<0.001) minutes post-capsaicin in comparison to FAAH KO animals receiving AM251).One-way ANOVA shows that AM251 (AM-251) injected into the rats significantly decreases both of the percentage of entries in the open arms and time spent in the open arms,compare to controls.The Tukey-Kramer test analysis reveals a significant reduction for the doses of 1mg/kg (P<0.05) and 5mg/kg (P<0.01) compare to control rats in the time spent in the open arms.Also,AM251 significantly decreases percentage of entries in the open arms for the doses of 1 and 5mg/kg (P<0.05). |
推荐实验方法(仅供参考)
激酶实验: |
Macrophages are seeded (2×106/well) in 12-well culture plates.AM-251 or SR144528 are added from 4mM stock solutions prepared in DMSO,1h prior to the addition of 7-ketocholesterol (7KC) from a 2mg/mL ethanol stock solution.Controls are adjusted to receive equivalent volumes of DMSO and ethanol.After 16h,caspase-3 activity is determined. All treatments are done in triplicate and the data presented as the mean RFLU/mg protein±SD. |
动物实验: |
|
Mice A total of 246 mice weighing 17-48g are used in these experiments.Following determination of baseline responding,mice receive a single i.p injection (5mL/kg) of AMG9810 (3mg/kg,n=5 per group),AM251 (3mg/kg,n=5 per group),or vehicle (n=6 per group).I.p.injections are performed 30 min prior to i.pl.capsaicin or vehicle administration.Paw withdrawal latencies are assessed before and 10,30,60,90 and 120 min after intradermal injection of capsaicin or vehicle.Paw withdrawal latencies are measured in duplicate in each paw at each time point,and are reported as the mean of the two duplicate determinations from each animal,averaged across subjects. Rats Male Wistar rats weighting 250-350 are used.The following agents are used:CB1 receptor agonist,Win-55212 (0.3,1 and 5mg/kg,i.p.);CB1 receptor antagonist,AM251 (0.3,1 and 5mg/kg,i.p.);endocannabinoid breakdown inhibitor,URB-597 (0.03,0.1 and 0.3mg/kg,i.p.) in the study.Physiological saline (0.9% sodium chloride) is used as the vehicle.All drugs are prepared freshly and administered intraperitoneally (i.p.) in a volume of 0.1mL per 10g of body weight of the rats.All substances are dissolved in physiological saline and are administrated 30 min before elevated plus-maze test. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )